Popular Articles From: ChromaDex Signs Material Transfer Agreement With Prominent Australian Research Institute for NIAGEN™ Research to CBRE Group, Inc. Enhances Service Offering with Acquisition of Louisville, Kentucky-Based Affiliate Company


- NIAGEN™ is the first and only commercially available Nicotinamide Riboside - IRVINE, Calif.
Sign-up for ChromaDex Signs Material Transfer Agreement With Prominent Australian Research Institute for NIAGEN™ Research investment picks
Christopher & Banks Corporation (NYSE:CBK), a specialty women’s apparel retailer, today reported results for the thirteen week period ended August 2, 2014.
Sign-up for Christopher & Banks Corporation Reports Results for the Thirteen Week Period Ended August 2, 2014 investment picks
Global hotel franchise opens Clarion Hotel Istanbul Airport North ROCKVILLE, Md.
Sign-up for Choice Hotels Continues International Expansion In Turkey investment picks
BEIJING, Aug.
Sign-up for ChinaNet Online Holdings Signed Agreement With Baidu investment picks
HANGZHOU, China , Aug.
Sign-up for China Shengda Packaging Group Inc. Reports Second Quarter 2014 Results investment picks
Dr. Wei Shaojun awarded the Lifetime Achievement Award: China Semiconductor Industry and Genda Hu of Focal Tech honored as Executive of the Year SHENZHEN, China , Sept.
Sign-up for China ACE Awards 2014 -- ADI, Broadcom, Intel, Keysight, Linear Technology, Maxim Integrated, Qualcomm, TE Connectivity, Texas Instruments and Vimicro among winners investment picks
DURHAM, N.C., Aug.
Sign-up for Chimerix Announces Second Quarter 2014 Financial Results investment picks
Chimera Investment Corporation (NYSE:CIM) today announced that its Board of Directors has set the date for the Company's Annual Meeting of Shareholders (the “Annual Meeting”) as well as the record date for shareholders eligible to vote at the meeting.
Sign-up for Chimera Investment Corporation Sets Date for the Company’s 2014 Annual Meeting of Shareholders investment picks
Changing Technologies, Inc. (OTCBB: CHGT) announced today that its Board of Directors and stockholders holding a majority of voting shares approved a five-for-one stock dividend.
Sign-up for CHGT Announces Five-for-One Stock Dividend investment picks
Second Quarter 2014 Net Sales up 3%, GAAP net earnings from continuing operations of $0.46 per diluted share and net earnings from continuing operations of $0.32 per diluted share on a managed basis PHILADELPHIA, July 29, 2014 (GLOBE NEWSWIRE) -- Chemtura Corporation, (NYSE: CHMT) (Euronext Paris:CHMT) (the "Company," "Chemtura," "We," "Us" or "Our") today announced financial results for the second quarter ended June 30, 2014.
Sign-up for Chemtura Reports Second Quarter 2014 Financial Results investment picks
MOUNTAIN VIEW, Calif., Aug.
Sign-up for ChemoCentryx Announces Financial Results for the Second Quarter Ended June 30, 2014 investment picks
Clean Master app can now cool phones protecting both devices and users SAN FRANCISCO , Aug.
Sign-up for Cheetah Mobile Releases New Patent-Pending Device Cooling Technology In Updated Clean Master App investment picks
CLEVELAND, July 31, 2014 (GLOBE NEWSWIRE) -- Chart Industries, Inc. (Nasdaq:GTLS) today announced that Bechtel has awarded Chart's wholly-owned subsidiary, Chart Energy & Chemicals, Inc. ("Chart E&C"), a contract to provide Chart's proprietary IPSMR® liquefaction technology and C450IMR LNG standard liquefaction plant equipment for the FortisBC Tilbury Expansion Project in British Columbia, Canada.
Sign-up for Chart E&C Receives LNG Liquefaction Plant Order From Bechtel investment picks
CLEVELAND, July 31, 2014 (GLOBE NEWSWIRE) -- Chart Industries, Inc. (Chart) (Nasdaq:GTLS) today announced that Black & Veatch has awarded its wholly-owned subsidiary, Chart Energy & Chemicals, Inc., a contract in excess of $20 million for the supply of brazed aluminum heat exchangers (BAHX) and cold boxes for the recently announced Golar LNG Limited (Nasdaq: GLNG) floating liquefied natural gas (FLNG) project.
Sign-up for Chart E&C Receives FLNG Liquefaction Equipment Order From Black & Veatch investment picks
Chambers Street Properties (NYSE:CSG), a real estate investment trust focused on acquiring, owning and operating net leased industrial and office properties, announced it has purchased 1 Rocket Road, an industrial property of approximately 510,000 square feet in Hawthorne, California, for $46.7 million.
Sign-up for Chambers Street Acquires the Headquarters of Space Exploration Technologies (SpaceX) investment picks
Cerus Corporation (NASDAQ:CERS) announced today that it has submitted a clinical protocol to the U.S. Food and Drug Administration (FDA) to make the INTERCEPT Blood System for platelets available under an Expanded Access Investigational Device Exemption (IDE) to regions in the United States with outbreaks of Chikungunya and dengue.
Sign-up for Cerus Submits IDE Supplement to Make INTERCEPT Platelets Available Pre-Approval in U.S. Areas at Risk from Outbreaks of Chikungunya and Dengue investment picks
STAMFORD, Conn.
Sign-up for Cenveo to Present at Upcoming Investor Conferences investment picks
http://media.marketwire.com/attachments/200510/225875_century_aluminum_logo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1134416&ProfileId=051205&sourceType=1 CHICAGO, IL --
Sign-up for Century Reports Second Quarter 2014 Financial Results investment picks
- Qualified Infectious Disease Product (QIDP) Granted for Solithromycin Capsules by the FDA - CHAPEL HILL, N.C., Aug.
Sign-up for Cempra Initiates Phase 3 Clinical Trial in Patients With Uncomplicated Gonorrhea Infection investment picks
MADISON, Wis., Aug.
Sign-up for Cellular Dynamics International Reports Second Quarter 2014 Financial Results investment picks
SAN DIEGO, July 21, 2014 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN) , a clinical-stage biotechnology company applying its leadership position in the field of gene therapy and calcium dysregulation today announced an exclusive, global license from Enterprise Partners Venture Capital for gene therapy applications of the membrane-bound form of the Stem Cell Factor gene (mSCF) for treatment of cardiac ischemia.
Sign-up for Celladon Corporation Announces In-License of Stem Cell Factor Development Program investment picks
PORT WASHINGTON, N.Y. , Sept.
Sign-up for Cedar Realty Trust Announces Appointment of New Chief Operating Officer and New Head of Leasing investment picks
VERNON HILLS, Ill., Aug.
Sign-up for CDW Corporation Announces Partial Redemption of Senior Notes Due 2019 investment picks
CBRE Group, Inc. (NYSE:CBG) today announced that it has acquired CBRE | Louisville, a commercial real estate services firm that has served as CBRE’s affiliate in metropolitan Louisville, Kentucky and southern Indiana since 1996.
Sign-up for CBRE Group, Inc. Enhances Service Offering with Acquisition of Louisville, Kentucky-Based Affiliate Company investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Popular Articles From: ChromaDex Signs Material Transfer Agreement With Prominent Australian Research Institute for NIAGEN™ Research to CBRE Group, Inc. Enhances Service Offering with Acquisition of Louisville, Kentucky-Based Affiliate Company
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices